Filing Details
- Accession Number:
- 0001371285-25-000070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-27 19:53:44
- Reporting Period:
- 2025-02-25
- Filing Date:
- 2025-02-27
- Accepted Time:
- 2025-02-27 19:53:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1371285 | Trupanion Inc. | TRUP | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1995789 | Fawwad Qureshi | 6100 4Th Avenue South Suite 200 Seattle WA 98108 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-25 | 3,750 | $0.00 | 5,123 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-25 | 1,334 | $34.12 | 3,789 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2025-02-26 | 1,373 | $34.22 | 2,416 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2025-02-25 | 3,750 | $0.00 | 3,750 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 41,250 | 2027-11-25 | No | 4 | M | Direct |
Footnotes
- Restricted stock units convert into common stock on a one-for-one basis.
- This Form 4 discloses the shares of common stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting of the restricted stock units, and does not represent a sale by the reporting person.
- The sale reported is effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 17, 2024, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.8350 to $34.7900 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
- On November 13, 2023, the reporting person was granted 60,000 restricted stock units (RSUs). The RSUs vest and convert into common stock of the Issuer as to 1/4th of the total shares on 11/25/24, after which 1/16th of the total shares vest quarterly, subject to continued service through each vest date.
Billionaire Hedge Funds
